219 related articles for article (PubMed ID: 26332539)
1. Pharmacokinetics, pharmacodynamics, and safety of USL261, a midazolam formulation optimized for intranasal delivery, in a randomized study with healthy volunteers.
Bancke LL; Dworak HA; Rodvold KA; Halvorsen MB; Gidal BE
Epilepsia; 2015 Nov; 56(11):1723-31. PubMed ID: 26332539
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics, pharmacodynamics, and tolerability of USL261, midazolam nasal spray: Randomized study in healthy geriatric and non-geriatric adults.
Berg AK; Myrvik MJ; Van Ess PJ
Epilepsy Behav; 2017 Jun; 71(Pt A):51-59. PubMed ID: 28544992
[TBL] [Abstract][Full Text] [Related]
3. Safety and efficacy of midazolam nasal spray for the treatment of intermittent bouts of increased seizure activity in the epilepsy monitoring unit: A double-blind, randomized, placebo-controlled trial.
Spencer DC; Sinha SR; Choi EJ; Cleveland JM; King A; Meng TC; Pullman WE; Sequeira DJ; Van Ess PJ; Wheless JW
Epilepsia; 2020 Nov; 61(11):2415-2425. PubMed ID: 33140403
[TBL] [Abstract][Full Text] [Related]
4. A pharmacokinetic and pharmacodynamic study, in healthy volunteers, of a rapidly absorbed intranasal midazolam formulation.
Wermeling DP; Record KA; Archer SM; Rudy AC
Epilepsy Res; 2009 Feb; 83(2-3):124-32. PubMed ID: 19046855
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics and tolerability of nasal versus intravenous midazolam in healthy Dutch volunteers: a single-dose, randomized-sequence, open-label, 2-period crossover pilot study.
Veldhorst-Janssen NM; Fiddelers AA; van der Kuy PH; Theunissen HM; de Krom MC; Neef C; Marcus MA
Clin Ther; 2011 Dec; 33(12):2022-8. PubMed ID: 22078155
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics and pharmacodynamics of a new intranasal midazolam formulation in healthy volunteers.
Wermeling DP; Record KA; Kelly TH; Archer SM; Clinch T; Rudy AC
Anesth Analg; 2006 Aug; 103(2):344-9, table of contents. PubMed ID: 16861415
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics and tolerability of intranasal diazepam and midazolam in healthy adult volunteers.
Ivaturi VD; Riss JR; Kriel RL; Cloyd JC
Acta Neurol Scand; 2009 Nov; 120(5):353-7. PubMed ID: 19456308
[TBL] [Abstract][Full Text] [Related]
8. Assessment of pharmacokinetics and tolerability of intranasal diazepam relative to rectal gel in healthy adults.
Henney HR; Sperling MR; Rabinowicz AL; Bream G; Carrazana EJ
Epilepsy Res; 2014 Sep; 108(7):1204-11. PubMed ID: 24934774
[TBL] [Abstract][Full Text] [Related]
9. Efficacy, Tolerability, and Safety of Concentrated Intranasal Midazolam Spray as Emergency Medication in Epilepsy Patients During Video-EEG Monitoring.
von Blomberg A; Kay L; Knake S; Fuest S; Zöllner JP; Reif PS; Herrmann E; Balaban Ü; Schubert-Bast S; Rosenow F; Strzelczyk A
CNS Drugs; 2020 May; 34(5):545-553. PubMed ID: 32219682
[TBL] [Abstract][Full Text] [Related]
10. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions.
Chen C; Bujanover S; Kareht S; Rapoport AM
Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369
[TBL] [Abstract][Full Text] [Related]
11. A Randomized Trial Comparing the Pharmacokinetics, Safety, and Tolerability of DFN-02, an Intranasal Sumatriptan Spray Containing a Permeation Enhancer, With Intranasal and Subcutaneous Sumatriptan in Healthy Adults.
Munjal S; Gautam A; Offman E; Brand-Schieber E; Allenby K; Fisher DM
Headache; 2016 Oct; 56(9):1455-1465. PubMed ID: 27613076
[TBL] [Abstract][Full Text] [Related]
12. Intranasal midazolam during presurgical epilepsy monitoring is well tolerated, delays seizure recurrence, and protects from generalized tonic-clonic seizures.
Kay L; Reif PS; Belke M; Bauer S; Fründ D; Knake S; Rosenow F; Strzelczyk A
Epilepsia; 2015 Sep; 56(9):1408-14. PubMed ID: 26216711
[TBL] [Abstract][Full Text] [Related]
13. A pilot study assessing the bioavailability and pharmacokinetics of diazepam after intranasal and intravenous administration in healthy volunteers.
Agarwal SK; Kriel RL; Brundage RC; Ivaturi VD; Cloyd JC
Epilepsy Res; 2013 Aug; 105(3):362-7. PubMed ID: 23561287
[TBL] [Abstract][Full Text] [Related]
14. Nonintravenous midazolam versus intravenous or rectal diazepam for the treatment of early status epilepticus: A systematic review with meta-analysis.
Brigo F; Nardone R; Tezzon F; Trinka E
Epilepsy Behav; 2015 Aug; 49():325-36. PubMed ID: 25817929
[TBL] [Abstract][Full Text] [Related]
15. Intranasal midazolam in piglets: pharmacodynamics (0.2 vs 0.4 mg/kg) and pharmacokinetics (0.4 mg/kg) with bioavailability determination.
Lacoste L; Bouquet S; Ingrand P; Caritez JC; Carretier M; Debaene B
Lab Anim; 2000 Jan; 34(1):29-35. PubMed ID: 10759364
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics and pharmacodynamics of midazolam administered as a concentrated intranasal spray. A study in healthy volunteers.
Knoester PD; Jonker DM; Van Der Hoeven RT; Vermeij TA; Edelbroek PM; Brekelmans GJ; de Haan GJ
Br J Clin Pharmacol; 2002 May; 53(5):501-7. PubMed ID: 11994056
[TBL] [Abstract][Full Text] [Related]
17. Intranasal midazolam: a comparison of two delivery devices in human volunteers.
Dale O; Nilsen T; Loftsson T; Hjorth Tønnesen H; Klepstad P; Kaasa S; Holand T; Djupesland PG
J Pharm Pharmacol; 2006 Oct; 58(10):1311-8. PubMed ID: 17034653
[TBL] [Abstract][Full Text] [Related]
18. Safety, Pharmacokinetics, and Pharmacodynamics of Midazolam Gel After Rectal Administration in Healthy Chinese Subjects.
Zhou S; Zhu J; Sun X; Xie L; Zhao Y; Ding S; Wang L; Chen J; Zhu B; Zheng A; Li Y; Zhou C; Shao F
Clin Drug Investig; 2023 Jun; 43(6):421-433. PubMed ID: 37270744
[TBL] [Abstract][Full Text] [Related]
19. STOP 101: A Phase 1, Randomized, Open-Label, Comparative Bioavailability Study of INP104, Dihydroergotamine Mesylate (DHE) Administered Intranasally by a I123 Precision Olfactory Delivery (POD
Shrewsbury SB; Jeleva M; Satterly KH; Lickliter J; Hoekman J
Headache; 2019 Mar; 59(3):394-409. PubMed ID: 30659611
[TBL] [Abstract][Full Text] [Related]
20. Bioavailability and Safety of a New Highly Concentrated Midazolam Nasal Spray Compared to Buccal and Intravenous Midazolam Treatment in Chinese Healthy Volunteers.
Wang H; Huang J; Yang S; Zhang XF; Yang X; Cui C; Zou C; Li LE; Zhang M; Mao MF; Zhou X; Duan KM; Wang SY; Yang GP
Neurol Ther; 2022 Jun; 11(2):621-632. PubMed ID: 35129802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
